A clinical formulation indicated for Antibiotics applications. Inhibiting bacterial protein synthesis, this option supports the body in recovering from severe localized infections.
A synthetic antibiotic developed to manage serious drug-resistant bacterial infections and intended to alleviate symptoms of severe pneumonia and complex skin infections.
Mechanism of Action
It works by inhibiting the initiation phase of bacterial protein synthesis. By binding to a specific site on the ribosome, it prevents the bacteria from multiplying.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
12 hours
Contraindications
Allergy to linezolid, Recent use of MAOIs (within 2 weeks), Uncontrolled hypertension
Information for Zyvox is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
